Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 66 out of 100. Genetics

Topic: Amyloid, tau and blood-test diagnosis

This study asked whether the genes that raise Alzheimer's risk are the same genes that cause amyloid plaques to build up in the brain, and found they are not quite the same thing. A combined genetic risk score improved prediction of who would get an Alzheimer's diagnosis, but it did not improve prediction of who would have amyloid plaques on a brain scan, suggesting some AD genetic risk works through pathways other than amyloid.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Leonenko, G., Shoai, M., Bellou, E., et al. (2019). Genetic risk for Alzheimer disease is distinct from genetic risk for amyloid deposition. Annals of Neurology. https://doi.org/10.1002/ana.25530

Vancouver

Leonenko G, Shoai M, Bellou E, et al. Genetic risk for Alzheimer disease is distinct from genetic risk for amyloid deposition. Annals of Neurology. 2019. doi:10.1002/ana.25530. PMID: 31199530.

BibTeX

@article{leonenko2019-0e415d77,
  author  = {Leonenko, G. and Shoai, M. and Bellou, E. and others},
  title   = {{Genetic risk for Alzheimer disease is distinct from genetic risk for amyloid deposition}},
  journal = {Annals of Neurology},
  year    = {2019},
  doi     = {10.1002/ana.25530},
  pmid    = {31199530},
  url     = {https://doi.org/10.1002/ana.25530}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

This study asked whether the genes that raise Alzheimer's risk are the same genes that cause amyloid plaques to build up in the brain, and found they are not quite the same thing. A combined genetic risk score improved prediction of who would get an Alzheimer's diagnosis, but it did not improve prediction of who would have amyloid plaques on a brain scan, suggesting some AD genetic risk works through pathways other than amyloid.

Study details

Limitations

Relatively small single-cohort (ADNI) sample, particularly for the amyloid-positive MCI subgroup (n=270); AUC estimates from a single cohort may not replicate precisely in independent populations.

How this study scored 66/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record left out, no data; Study design 6 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 2 of 5; Sample size 2 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here 0 of 6; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multi-centre collaboration left out, no data; Indexed in PubMed 2 of 2; Free to read 2 of 2. 42 of the 64 points it could be judged on, which is 66 of 100. Total 66 of 100.42 of the 64 points we could judge = 66 of 100

Published in a leading specialty journal, and it is a case-control study. Scored zero for randomised / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, still being cited, senior author's track record, institution's track record and multi-centre collaboration, so those were left out: it earned 42 of the 64 points we could judge it on, which is 66 out of 100.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (Annals of Neurology)
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 6 / 12 A case-control study
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 2 / 5 2019 — within 10 year(s) of the newest study here
Sample size 2 / 4 770 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 31199530)
Free to read 2 / 2 Free to read
Points 42 / 64 Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 42 of the 64 points we could judge it on is 66 out of 100.
Total 66 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 16.

Later studies that cite this one

7 studies in the alzhub library list this one in their references.

Related studies in Genetics

Also in Genetics

214 studies in the library are filed under Genetics with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Genetics hub.

Similar studies

More on Genetics

See all studies in Genetics →